G. Pasterkamp

Shrinkage of human coronary arteries is an important determinant of de novo atherosclerotic luminal stenosis: an in vivo intravascular ultrasound study

F. Eefting, L. Bos, Pieter C. Smits, 1998, Heart.

Shrinkage of human coronary arteries is an important determinant of de novo atherosclerotic luminal stenosis : an in vivo intravascular ultrasound study

G. Pasterkamp, C. Borst, P. Smits, 1998 .

Plaque burden, arterial remodeling and plaque vulnerability: determined by systemic factors?

E. Falk, G. Pasterkamp, A. Vink, 2001, Journal of the American College of Cardiology.

Atherosclerotic lesion development and Toll like receptor 2 and 4 responsiveness.

J. Sluijter, G. Pasterkamp, J. Laman, 2008, Atherosclerosis.

Toll-like receptor 2 stimulation induces intimal hyperplasia and atherosclerotic lesion development.

G. Pasterkamp, J. Laman, D. D. de Kleijn, 2005, Cardiovascular research.

Peptidoglycan in atherosclerotic plaque formation and vulnerability

M. M. Nijhuis, D. P. Kleijn, M. Nijhuis, 2006 .

Leukocyte TLR5 deficiency inhibits atherosclerosis by reduced macrophage recruitment and defective T-cell responsiveness

I. Hoefer, S. D. de Jager, G. Ellenbroek, 2017, Scientific Reports.

Vascular Remodeling and Protease Inhibition—bench to Bedside

J. Sluijter, G. Pasterkamp, D. D. de Kleijn, 2022 .